Global Menin Inhibitor Drugs Clinical Trials & Insight
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Page 2 - Early Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Early Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Early Phase Today - Breaking & Trending Today
Worldwide Clinical Trials Completes Recapitalization with Kohlberg & Company
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
Source: financialpost.com
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
Pooled analysis of the FELIX Phase Ib/II study demonstrated prolonged event free survival and low overall immunotoxicity across all cohorts in r/r B-ALL, and particularly in patients with low leukemic...
Source: marketscreener.com
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase
ADI-001 showed robust dose-dependent expansion and persistence in patients with relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma (NHL)Strong exposure and persistence profile further supports Adicet’s allogeneic chimeric antigen receptor (CAR) T platform potential as best-in-classPharmacodynamic (PD) and...
Source: pharmiweb.com
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
ADI-001 showed robust dose-dependent expansion and persistence in patients with relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma Strong exposure and persistence profile further...
Source: marketscreener.com